News

Amarvir Gill, President, CEO and Director of Biosenta acquired 1,250,000 common shares and 625,000 warrants.

Biosenta announces that it has entered into debt settlement agreements with certain creditors.

Biosenta enters into debt settlement agreements with certain creditors.

Discover Biosenta's exciting engagement with Oak Hill Financial, offering insight into their business and capital markets advisory services.

Discover how Biosenta successfully closed a private placement financing of $500,000 for its future growth and development.